Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

RMD open

Showing results (391-400 of 2,090) with videos related to

Pageof 209
Sort By:
RMD Open|December 10, 2024
Lymph nodes as gatekeepers of autoimmune diseasesAoife M O'Byrne, Lisa G M van Baarsen
RMD Open|September 6, 2024
Development of a multivariable prediction model for progression of systemic sclerosis-associated interstitial lung diseaseMasataka Kuwana, Jerôme Avouac, Anna-Maria Hoffmann-Vold, et al.
RMD Open|August 29, 2024
Fcγ-receptor-IIIA bioactivity of circulating and synovial immune complexes in rheumatoid arthritisIvana Andreeva, Philipp Kolb, Lea Rodon, et al.
RMD Open|August 19, 2024
Sensitivity of classification criteria from time of diagnosis in an incident systemic lupus erythematosus cohort: a population-based study from NorwayHilde Haukeland, Sigrid Reppe Moe, Cathrine Brunborg, et al.
RMD Open|August 30, 2024
Successful management of pre-existing psoriatic arthritis through targeting the IL-23/IL-17 axis in cancer patients receiving immune checkpoint inhibitor therapy: a case seriesYuanteng Jeff Li, Pavlos Msaouel, Matthew Campbell, et al.
RMD Open|August 29, 2024
Clinical, biological, prognostic characteristics of patients with immune-mediated thrombotic thrombocytopenic purpura and Sjögren's diseaseJustine Luciano, Laurent Gilardin, Gaétane Nocturne, et al.
RMD Open|August 23, 2024
Long-term safety and efficacy of anti-TNF multivalent VHH antibodies ozoralizumab in patients with rheumatoid arthritisYoshiya Tanaka, Yusuke Miyazaki, Masafumi Kawanishi, et al.
RMD Open|November 8, 2024
Remission versus low disease activity as treatment targets in rheumatoid arthritis: how to strike the right balance between too strict and too lenient targets? A meta-epidemiological study of individual patient dataCatia Duarte, Johannes W G Jacobs, Ricardo J O Ferreira, et al.
RMD Open|November 18, 2024
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profileSilvia Bellando-Randone, Edda Russo, Leandro Di Gloria, et al.
RMD Open|November 18, 2024
Arthritis progressors have a decreased frequency of circulating autoreactive T cells during the at-risk phase of rheumatoid arthritisSara Turcinov, Ravi Kumar Sharma, Charlotte De Vries, et al.
Pageof 209

Showing results (391-400 of 2,090) with videos related to

Sort By:
Pageof 209
RMD Open|December 10, 2024
Lymph nodes as gatekeepers of autoimmune diseasesAoife M O'Byrne, Lisa G M van Baarsen
RMD Open|September 6, 2024
Development of a multivariable prediction model for progression of systemic sclerosis-associated interstitial lung diseaseMasataka Kuwana, Jerôme Avouac, Anna-Maria Hoffmann-Vold, et al.
RMD Open|August 29, 2024
Fcγ-receptor-IIIA bioactivity of circulating and synovial immune complexes in rheumatoid arthritisIvana Andreeva, Philipp Kolb, Lea Rodon, et al.
RMD Open|August 19, 2024
Sensitivity of classification criteria from time of diagnosis in an incident systemic lupus erythematosus cohort: a population-based study from NorwayHilde Haukeland, Sigrid Reppe Moe, Cathrine Brunborg, et al.
RMD Open|August 30, 2024
Successful management of pre-existing psoriatic arthritis through targeting the IL-23/IL-17 axis in cancer patients receiving immune checkpoint inhibitor therapy: a case seriesYuanteng Jeff Li, Pavlos Msaouel, Matthew Campbell, et al.
RMD Open|August 29, 2024
Clinical, biological, prognostic characteristics of patients with immune-mediated thrombotic thrombocytopenic purpura and Sjögren's diseaseJustine Luciano, Laurent Gilardin, Gaétane Nocturne, et al.
RMD Open|August 23, 2024
Long-term safety and efficacy of anti-TNF multivalent VHH antibodies ozoralizumab in patients with rheumatoid arthritisYoshiya Tanaka, Yusuke Miyazaki, Masafumi Kawanishi, et al.
RMD Open|November 8, 2024
Remission versus low disease activity as treatment targets in rheumatoid arthritis: how to strike the right balance between too strict and too lenient targets? A meta-epidemiological study of individual patient dataCatia Duarte, Johannes W G Jacobs, Ricardo J O Ferreira, et al.
RMD Open|November 18, 2024
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profileSilvia Bellando-Randone, Edda Russo, Leandro Di Gloria, et al.
RMD Open|November 18, 2024
Arthritis progressors have a decreased frequency of circulating autoreactive T cells during the at-risk phase of rheumatoid arthritisSara Turcinov, Ravi Kumar Sharma, Charlotte De Vries, et al.
Pageof 209